Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 861-864

  Cauff, Brian E ^a,b   Quinn, Charles T ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aplastic crisis; Hereditary spherocytosis; Neutropenia; Pancytopenia; Parvovirus; Thalassemia; Thrombocytopenia

Indexed keywords

APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL; CHILD; CLINICAL ARTICLE; HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HOSPITAL PATIENT; HUMAN; HYPOPLASIA; PANCYTOPENIA; PARVOVIRUS INFECTION; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC; BLOOD CELLS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS;

EID: 40449129438     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21426     Document Type: Article

References (19)

1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002;15:485-505.
2. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586-597.
3. Kelleher JF, Luban NL, Mortimer PP, et al. Human serum "parvovirus": A specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr 1983;102:720-722.
4. Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;1:664-665.
5. Serjeant GR, Topley JM, Mason K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981;2:595-597.
6. Gahr M, Pekrun A, Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr 1991; 150:470-472.
7. Hasle H, Kerndrup G, Jacobsen BB, et al. Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency. Am J Pediatr Hematol Oncol 1994; 16:329-333.
8. Kurtzman GJ, Ozawa K, Cohen B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987;317:287-294.
9. Graeve JL, de Alarcon PA, Naides SJ. Parvovirus B19 infection in patients receiving cancer chemotherapy: The expanding spectrum of disease. Am J Pediatr Hematol Oncol 1989;11:441-444.
10. Nigro G, Gattinara GC, Mattia S, et al. Parvovirus-B19-related pancytopenia in children with HIVinfection. Lancet 1992;340:115.
11. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152:257-265.
12. Istomin V, Sade E, Grossman Z, et al. Agranulocytosis associated with parvovirus B19 infection in otherwise healthy patients. Eur J Intern Med 2004;15:531-533.
13. Kondo Y, Kakami M, Kawaguchi H, et al. Transient pancytopenia associated with parvovirus infection in a healthy child. Pediatr Int 2002;44:695-697.
14. Osaki M, Matsubara K, Iwasaki T, et al. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol 1999;78:83-86.
15. Hanada T, Koike K, Takeya T, et al. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol 1988;70:113-115.
16. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993;262:114-117.
17. Srivastava A, Bruno E, Briddell R, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990;76:1997-2004.
18. Shirono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol 1995;89:923-926.
19. Smith-Whitley K, Zhao H, Hodinka RL, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood 2004;103:422-427.